Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
Journal article
Pachchek S. et al, (2023), npj Parkinson's Disease, 9
Investigating gait-responsive somatosensory cueing from a wearable device to improve walking in Parkinson's disease.
Journal article
Li D. et al, (2023), Biomed Eng Online, 22
A programme evaluation of 'First Steps': A peer-conceived, developed and led self-management intervention for people after a Parkinson's diagnosis.
Journal article
Collett J. et al, (2023), Clin Rehabil
Investigation of the genetic aetiology of Lewy body diseases with and without dementia.
Journal article
Wu L. et al, (2023), medRxiv
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease.
Journal article
Martinez-Carrasco A. et al, (2023), NPJ Parkinsons Dis, 9
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Journal article
Street D. et al, (2023), Brain, 146, 3232 - 3242
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.
Journal article
Joza S. et al, (2023), Brain, 146, 3258 - 3272
Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study.
Journal article
Joza S. et al, (2023), Alzheimers Dement
HLA in isolated REM sleep behavior disorder and Lewy body dementia.
Journal article
Yu E. et al, (2023), Ann Clin Transl Neurol
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.
Journal article
Foltynie T. et al, (2023), Brain, 146, 2717 - 2722
NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.
Journal article
Somerville EN. et al, (2023), Neurobiol Aging, 127, 94 - 98
Reward insensitivity is associated with dopaminergic deficit in rapid eye movement sleep behaviour disorder
Journal article
Barber TR. et al, (2023), Brain, 146, 2502 - 2511
B lymphocyte responses in Parkinson's disease and their possible significance in disease progression.
Journal article
Scott KM. et al, (2023), Brain Commun, 5
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative.
Journal article
Gonzalez-Robles C. et al, (2023), J Parkinsons Dis, 13, 1013 - 1035
Neurofilament light levels predict clinical progression and death in multiple system atrophy.
Journal article
Chelban V. et al, (2022), Brain, 145, 4398 - 4408
Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects.
Journal article
Krohn L. et al, (2022), Nat Commun, 13
Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
Journal article
Pavelka L. et al, (2022), npj Parkinson's Disease, 8
Universal clinical Parkinson's disease axes identify a major influence of neuroinflammation.
Journal article
Sandor C. et al, (2022), Genome Med, 14
Association between the LRP1B and APOE loci in the development of Parkinson's disease dementia.
Journal article
Real R. et al, (2022), Brain
Identification of a possible proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF
Journal article
WINCHESTER L. and NEVADO-HOLGADO A., (2022), Brain Communications